Cytotoxic components of Bardanae Fructus (Goboshi)

50Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Bardanae Fructus (Goboshi) extract showed potent in vitro cytotoxicity and in vivo antitumor activity against human hepatoma HepG2 cells and mouse sarcoma 180 cells, respectively. In this study, the cytotoxicities of four fractions and three major components (arctiin, arctigenin, and chlorogenic acid) isolated from Goboshi extract were examined. Arctiin and arctigenin, which were contained in the ethylacetate fraction and n-butanol fraction, respectively, showed strong cytotoxicity against HepG2 cells, but little toxicity against Chang liver cells. Chlorogenic acid isolated from the water fraction did not affect the viability of these cells. The cytotoxicity of arctigenin against Chang liver cells was markedly potentiated by treatment with a glutathione (GSH) synthesis inhibitor, L-buthionine-(S,R)-sulfoximine (BSO). On the other hand, in HepG2 cells, the cytotoxicity of arctigenin was hardly changed by BSO. The cytotoxicity of arctigenin against HepG2 cells increased in an exposure-time dependent manner. These characteristics of arctigenin were similar to those of Goboshi extract, as previously observed. We therefore conclude thai the principal cytotoxic components of Goboshi extract are arctiin and its aglycone arctigenin.

Cite

CITATION STYLE

APA

Moritani, S., Nomura, M., Takeda, Y., & Miyamoto, K. I. (1996). Cytotoxic components of Bardanae Fructus (Goboshi). Biological and Pharmaceutical Bulletin, 19(11), 1515–1517. https://doi.org/10.1248/bpb.19.1515

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free